502.476.082 Boehringer Ingelheim Investigational Site — Selmer, Tennessee

502.476.082 Boehringer Ingelheim Investigational Site is a clinical research site located in Selmer, Tennessee, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

502.476.082 Boehringer Ingelheim Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Hypertension.

Sponsors: Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Selmer

Browse all research sites in Tennessee · View every site in Selmer

• Local Institution
• GSK Investigational Site
• Pfizer Investigational Site
• Site Reference # / Investigator 1727
• 1235.1.382 Boehringer Ingelheim Investigational Site
• GSK Clinical Trial Call Center
• Prime Care Medical Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 502.476.082 Boehringer Ingelheim Investigational Site?

502.476.082 Boehringer Ingelheim Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 502.476.082 Boehringer Ingelheim Investigational Site conducted?

502.476.082 Boehringer Ingelheim Investigational Site has 1 clinical trials on record. Their work covers Hypertension.

Is 502.476.082 Boehringer Ingelheim Investigational Site accredited by Crixeo Clinical Trials?

502.476.082 Boehringer Ingelheim Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 502.476.082 Boehringer Ingelheim Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.